Effect of anti-inflammatory medication on the running-induced rise in patella tendon collagen synthesis in humans

Research output: Contribution to journalJournal articleResearchpeer-review

NSAIDs are widely used in the treatment of inflammatory diseases as well as of tendon diseases associated with pain in sports and labor. However, the effect of NSAID intake, and thus blockade of PGE(2) production, on the tendon tissue adaptation is unknown. The purpose of the present study was to elucidate the possible effects of NSAID intake on healthy tendon collagen turnover in relation to a strenuous bout of endurance exercise. Fifteen healthy young men were randomly assigned into two experimental groups, with one group receiving indomethacin (oral 2 × 100 mg Confortid daily for 7 days; NSAID; n = 7) and a placebo group (n = 8). Both groups were exposed to a prolonged bout of running (36 km). The collagen synthesis NH2-terminal propeptide of type I (PINP) and PGE2 concentrations were measured before and 72 h following the run in the patella tendon by microdialysis. The peritendinous concentrations of PINP increased significantly in the placebo group as a result of the run, as shown previously. PGE2 levels were significantly decreased 72 h after the run compared with basal levels in the subjects treated with NSAID and unchanged in the placebo group. The NSAID intake abolished the adaptive increase in collagen synthesis in the patella tendon found in the placebo group in response to the prolonged exercise (P <0.05). The present study demonstrates that intake of NSAID decreased interstitial PGE2 and abolished the exercise-induced adaptive increase in collagen synthesis in human tendons.
Original languageEnglish
JournalJournal of Applied Physiology
Issue number1
Pages (from-to)137-41
Number of pages5
Publication statusPublished - 2011

    Research areas

  • Adult, Anti-Inflammatory Agents, Non-Steroidal, Collagen, Dinoprostone, Dose-Response Relationship, Drug, Female, Humans, Indomethacin, Male, Patellar Ligament, Physical Endurance, Running, Up-Regulation

ID: 38363716